Skip to main content

Table 3 Baseline laboratory results of LN patients at the renal clinic of St. Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia from Sep, 2016 to Oct, 2020

From: Management practice and treatment outcomes of adult patients with Lupus Nephritis at the Renal Clinic of St. Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia

Variables

Number of patients (n)

Mean ± SD or %

Hg (mg/dl)

114

11.80 ± 2.94

WBC (× 103/mm3)

114

7.40 ± 3.60

PLT (× 103/mm3)

114

259.88 ± 134.24

ESR (mm/hour)

44

56.22 ± 36.51

Serum albumin (mg/dl)

53

2.77 ± 0.64

Creatinine (mg/dl)

114

2.45 ± 2.17

CKD-EPI eGFR (ml/min)

114

58.36 ± 42.31

Urea (mg/dl)

114

81.79 ± 52.42

Urine proteins (g/24 h)

114

4.47 ± 2.24

ANA (positive)

85

74.6

Anti-dsDNA (positive)

31

27.2

C3 (low)

44

38.6

C4 (low)

38

33.3

LA (positive)

11

9.6

SBP at onset of LN (mmHg)

114

129.52 ± 19.96

DBP at onset of LN (mmHg)

114

82.59 ± 14.32

Lupus class/kidney biopsy (%)

71

 

Class II

 

3(4.2)

Class III

 

20(28.2)

Class IV

 

28(39.4)

Class V

 

5(7.0)

Class III/V

 

7(9.9)

Class IV/V

 

8(11.3)

CKD-EPI eGFR Stages (%)

114

 

Stage 1

 

25(21.9)

Stage 2

 

19(16.7)

Stage 3

 

34(29.8)

Stage 4

 

20(17.5)

Stage 5

 

16(14.0)

Mean follow up period (months)

114

27.93 ± 17.15

  1. SD standard deviation, Hg hemoglobin, WBC white blood cells, PLT platelets, ESR erythrocyte sedimentation rate, CKD-EPI eGFR chronic kidney disease epidemiology collaboration estimated glomerular filtration rate, ANA antinuclear antibody, Anti-dsDNA anti-double strand DNA, C3&C4 complement levels, LA lupus anticoagulants, SBP systolic blood pressure, DBP diastolic blood pressure